Clinical Trial Update: EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating amifostine for mucosal and hematopoietic protection in combination with carboplatin, paclitaxel (Taxol), and radiotherapy for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• ETHYOL (Amifostine)
• Taxol (paclitaxel)

Snippet

Sponsor: Mohan Suntharalingam | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-08